| Authors: |
Falade AS; Mayo Clinic, Rochester, MN., Redd R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Desai SH; Mayo Clinic, Rochester, MN.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY., Shah H; Division of Hematology, Department of Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Geyer SM; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Ganesan N; Memorial Sloan Kettering Cancer Center, New York, NY., Chang T; Memorial Sloan Kettering Cancer Center, New York, NY., Othman T; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Shah GL; Memorial Sloan Kettering Cancer Center, New York, NY., Nedved A; Mayo Clinic, Rochester, MN., Durani U; Mayo Clinic, Rochester, MN., Ng LS; Mayo Clinic, Rochester, MN., Baron K; Division of Hematology, Department of Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Ong SY; Department of Hematology, Singapore General Hospital, Singapore, Singapore., Yoon K; Department of Hematology and Medical Oncology, UCLA Medical Center Olive View, Los Angeles, CA., Ansell SM; Mayo Clinic, Rochester, MN., Iyengar S; Division of Medical Oncology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA., Micallef I; Mayo Clinic, Rochester, MN., Stuver R; Memorial Sloan Kettering Cancer Center, New York, NY., Herrera AF; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Mei M; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Armand P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Merryman RW; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. |
